PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsEtoposide phosphate
Etoposide phosphate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1916 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223—C85.91313921061943615
Lung neoplasmsD008175—C34.908220881528361
LeukemiaD007938—C959316092625327
Small cell lung carcinomaD055752——7118871426323
Non-hodgkin lymphomaD008228—C85.9601433459214
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.0327842917156
B-cell lymphomaD016393——55932227150
Large b-cell lymphoma diffuseD016403—C83.346872017138
Myeloid leukemia acuteD015470—C92.0425439113132
NeoplasmsD009369—C8056591819130
Show 25 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myeloid leukemiaD007951—C92405336—14127
CarcinomaD002277—C80.0165316—479
NeuroblastomaD009447EFO_0000621—203521—577
RecurrenceD012008——29457—673
SarcomaD012509——143518—669
Multiple myelomaD009101—C90.0124410—668
Plasma cell neoplasmsD054219——9399—459
Myelodysplastic syndromesD009190—D46222613—355
Central nervous system neoplasmsD016543——9287—548
PreleukemiaD011289——181912—244
Show 120 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
B-cell chronic lymphocytic leukemiaD015451—C91.1715——524
PlasmacytomaD010954—C90.3615——223
Hematologic neoplasmsD019337——77——316
B-cell lymphoma marginal zoneD018442—C88.457——312
Aids-related lymphomaD016483EFO_1001365—38——112
Graft vs host diseaseD006086—D89.8137——312
Neuroendocrine tumorsD018358EFO_1001901D3A.837——111
Adult t-cell leukemia-lymphomaD015459—C91.536——210
Lymphomatoid granulomatosisD008230—C83.844——39
T-cell lymphoma cutaneousD016410—C84.A42——38
Show 133 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Large granular lymphocytic leukemiaD054066——2———24
Neuroepithelial neoplasmsD018302——2————2
Pharyngeal neoplasmsD010610—C14.02————2
Peritoneal neoplasmsD010534——2————2
MelanomaD008545——2————2
Urethral neoplasmsD014523EFO_0003846—1————1
Esophageal squamous cell carcinomaD000077277——1————1
Deltaretrovirus infectionsD006800EFO_1001303—1————1
Htlv-i infectionsD015490EFO_0007316—1————1
Stem cell transplantationD033581——1————1
Show 21 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chediak-higashi syndromeD002609Orphanet_167D72.0————22
Paroxysmal hemoglobinuriaD006457Orphanet_447D59.12————11
HemoglobinuriaD006456—R82.3————11
Multiple primary neoplasmsD009378——————11
AtaxiaD001259—R27.0————11
Ataxia telangiectasiaD001260Orphanet_100G11.3————11
TelangiectasisD013684——————11
Cerebellar ataxiaD002524——————11
Peripheral blood stem cell transplantationD036102——————11
Hip osteoarthritisD015207EFO_1000786M16————11
Show 19 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameEtoposide phosphate
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
18 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use